262 related articles for article (PubMed ID: 21767594)
1. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
Paliwal PK; Bansal A; Sagi SS; Sairam M
Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
[TBL] [Abstract][Full Text] [Related]
2. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infection.
Bansal A; Paliwal PK; Sagi SS; Sairam M
Mol Cell Biochem; 2010 Apr; 337(1-2):213-21. PubMed ID: 19851830
[TBL] [Abstract][Full Text] [Related]
5. Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice.
Sagi SS; Paliwal P; Bansal A; Mishra C; Khan N; Mustoori SR; Ilavazhagan G; Sawhney RC; Banerjee PK
Vaccine; 2006 Nov; 24(49-50):7135-41. PubMed ID: 16887241
[TBL] [Abstract][Full Text] [Related]
6. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
7. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
8. rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.
Kaur G; STS C; Nimker C; Bansal A
Cell Mol Immunol; 2015 Jan; 12(1):96-106. PubMed ID: 24858422
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
10. Development of recombinant vaccine candidate molecule against Shigella infection.
Chitradevi STS; Kaur G; Sivaramakrishna U; Singh D; Bansal A
Vaccine; 2016 Oct; 34(44):5376-5383. PubMed ID: 27591952
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
Rafati S; Gholami E; Hassani N; Ghaemimanesh F; Taslimi Y; Taheri T; Soong L
Vaccine; 2007 May; 25(21):4159-69. PubMed ID: 17395340
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibodies against the lipopolysaccharide of Salmonella typhi 9,12,VI:d. Analysis of passive protection in a mouse model of typhoid fever].
Paniagua J; Isibasi A; Pelayo R; Ortiz V; Muy M; González C; García JA; Islas S
Arch Invest Med (Mex); 1989; 20(4):315-20. PubMed ID: 2488771
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic potential of cytolethal distending toxin B (CdtB) subunit of typhoid toxin against Typhoid fever.
Thakur R; Pathania P; Kaur N; Joshi V; Kondepudi KK; Suri CR; Rishi P
Sci Rep; 2019 Dec; 9(1):18404. PubMed ID: 31804525
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of immunogenic conjugates of Salmonella enterica serovar Typhi O-specific polysaccharides with diphtheria toxoid.
Ali A; An SJ; Cui C; Haque A; Carbis R
Hum Vaccin Immunother; 2012 Feb; 8(2):189-93. PubMed ID: 22426380
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines.
Tritama E; Riani C; Rudiansyah I; Hidayat A; Kharisnaeni SA; Retnoningrum DS
Hum Vaccin Immunother; 2018 Jun; 14(6):1524-1529. PubMed ID: 29359991
[TBL] [Abstract][Full Text] [Related]
16. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
Negi VD; Singhamahapatra S; Chakravortty D
Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
[TBL] [Abstract][Full Text] [Related]
17. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
Jazani NH; Parsania S; Sohrabpour M; Mazloomi E; Karimzad M; Shahabi S
Immunobiology; 2011 Jun; 216(6):744-51. PubMed ID: 21093956
[TBL] [Abstract][Full Text] [Related]
18. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
Jazani NH; Sohrabpour M; Mazloomi E; Shahabi S
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):54-62. PubMed ID: 21054579
[TBL] [Abstract][Full Text] [Related]
19. Immune response variations to Salmonella enterica serovar Typhi recombinant porin proteins in mice.
Toobak H; Rasooli I; Talei D; Jahangiri A; Owlia P; Darvish Alipour Astaneh S
Biologicals; 2013 Jul; 41(4):224-30. PubMed ID: 23796754
[TBL] [Abstract][Full Text] [Related]
20. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus.
Ge FF; Qiu YF; Yang YW; Chen PY
Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
